A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen
This study has been completed.
University of South Florida
Merck Sharp & Dohme Corp.
St. John's Research Institute
Information provided by (Responsible Party):
Charurut Somboonwit, University of South Florida
First received: September 5, 2008
Last updated: November 1, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||July 2011|
|Primary Completion Date:||July 2011 (Final data collection date for primary outcome measure)|